Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page
- ChecktodayChange DetectedRevision: v3.6.3 was added, replacing v3.6.2, indicating a platform update. This change does not affect the study details or other content on the page.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page revision updated from v3.6.0 to v3.6.2, indicating a newer build of the page. No study content or data appears to be affected.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a new Intervention/Treatment heading, along with a revision tag (Revision: v3.6.0). The recruitment status is updated to No longer looking for participants, indicating the study is no longer enrolling.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer build of the page. This reflects a small backend or UI update rather than changes to the study details.SummaryDifference0.0%

- Check51 days agoChange DetectedPage revision tag updated from v3.5.3 to v3.5.4, indicating a minor version update to the page. This change does not alter core content or user-facing features.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a site build or release change rather than any modification to the clinical trial record.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.